1. Home
  2. AREN vs ORKA Comparison

AREN vs ORKA Comparison

Compare AREN & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • ORKA
  • Stock Information
  • Founded
  • AREN 2016
  • ORKA 2004
  • Country
  • AREN United States
  • ORKA United States
  • Employees
  • AREN N/A
  • ORKA N/A
  • Industry
  • AREN Medical/Dental Instruments
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AREN Health Care
  • ORKA Health Care
  • Exchange
  • AREN Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • AREN 305.8M
  • ORKA 354.2M
  • IPO Year
  • AREN N/A
  • ORKA N/A
  • Fundamental
  • Price
  • AREN $5.92
  • ORKA $14.21
  • Analyst Decision
  • AREN
  • ORKA Strong Buy
  • Analyst Count
  • AREN 0
  • ORKA 8
  • Target Price
  • AREN N/A
  • ORKA $39.71
  • AVG Volume (30 Days)
  • AREN 307.7K
  • ORKA 364.0K
  • Earning Date
  • AREN 08-18-2025
  • ORKA 08-15-2025
  • Dividend Yield
  • AREN N/A
  • ORKA N/A
  • EPS Growth
  • AREN N/A
  • ORKA N/A
  • EPS
  • AREN 0.16
  • ORKA N/A
  • Revenue
  • AREN $128,781,000.00
  • ORKA N/A
  • Revenue This Year
  • AREN $275.98
  • ORKA N/A
  • Revenue Next Year
  • AREN N/A
  • ORKA N/A
  • P/E Ratio
  • AREN $26.59
  • ORKA N/A
  • Revenue Growth
  • AREN N/A
  • ORKA N/A
  • 52 Week Low
  • AREN $0.56
  • ORKA $5.49
  • 52 Week High
  • AREN $10.05
  • ORKA $52.32
  • Technical
  • Relative Strength Index (RSI)
  • AREN 53.20
  • ORKA N/A
  • Support Level
  • AREN $5.80
  • ORKA N/A
  • Resistance Level
  • AREN $6.83
  • ORKA N/A
  • Average True Range (ATR)
  • AREN 0.73
  • ORKA 0.00
  • MACD
  • AREN 0.04
  • ORKA 0.00
  • Stochastic Oscillator
  • AREN 58.55
  • ORKA 0.00

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: